Home / Business & Investment News / Braincure-Biotech.com Receives Financial Commitment of One Million Dollars

Braincure-Biotech.com Receives Financial Commitment of One Million Dollars

Related eBooks

Braincure-Biotech.com Receives Financial Commitment of One Million Dollars

Alzheimers Disease Research Company Receives $1,000,000 financial commitment which will enable it to Rapidly Advance Corporate Development

Online PR News – 06-November-2015 – Braincure-Biotech.com today announced that the company has executed an agreement with a large venture capital firm to purchase shares in value of 1 million USD. These funds will be used to support financial and business development goals that will help the company accelerate its research and testing programs, currently focused on the development of a new treatment in the fight against Alzheimers Disease.

Under the terms of the agreement, the Purchaser has agreed to purchase common stock at a per-share price of One Dollar ($1) per share, for a total purchase price of up to One Million Dollars ($1,000,000). In addition to the Shares, the Purchaser was issued a warrant to purchase shares of common stock of the Company at an exercise price of $2.50 per share. The number of shares underlying the Warrant will be equal to one share per $1.25 of the Purchase Price.

The venture company official declared, Our ability to formally engage with Braincure Biotech couldnt come at a better time. We are thrilled that we are able to commit to financially supporting the research and development of a novel method focused on evaluating an approach to Alzheimers Disease treatment that has been clinically recognized, but never before studied in a clinically significant way.

Braincure Biotech is working to establish a research foothold in an entirely new approach to the treatment of Alzheimers Disease. Never before has the need for effective treatments been greater, as incidence of this deadly and indiscriminate killer is expected to rise significantly in the next twenty five years, Suhon Horng, president and CEO of Braincure Biotech stated.

About Braincure Biotech
Braincure-Biotech.com is a state-of-the-art technology research company that uses discoveries in neuroimmunolgy and human genetics to develop novel therapeutics for Alzheimers disease, other forms of dementia, and mechanistically similar disorders. Braincure Biotechs strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. The goal of the firm is to discover and develop novel, disease modifying therapies for dementia and mechanistically similar disorders. The highly professional and acclaimed team of scientists maintains an innovative and motivating environment in which every employee has the possibility to contribute to our joint success and to grow individually.

Company Contact Information

Check Also

Consider Kirkland Lake Gold (KL), A Gold Mining Growth Stock

This week we are looking at another of the Investor’s Business Daily (IBD) Top 50 List companies.  We use this list in one of our options portfolios to spot outperforming stocks and place option spreads that take advantage of the momentum. Last week was a great one for the market (SPY up 2.6%) and an even better one for the Terry’s Tips 8 actual option portfolios.  Every one made gains, and the composite average picked up 11%, a record we are quite proud of.  Terry Consider Kirkland Lake Gold (KL), A Gold Mining Growth Stock The Investor’s Business Daily recently posted an article which started out by stating “Gold might not come to mind first when you think of growth stocks” which is very true.  Take a look at this article for the full write up and the reasoning behind why they see growth potential in this stock.  Also check out Kirkland Lake Gold Receives Consensus Rating of “Buy” from Analysts.

Leave a Reply

Your email address will not be published. Required fields are marked *